Riggs Asset Management’s Takeda Pharmaceutical TAK Stock Holding History

Riggs Asset Management’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-221	Closed	-$3.14K	–	685
2024 Q3	$3.14K	Hold	221	–	–	﹤0.01%	328
2024 Q2	$2.86K	Hold	221	–	–	﹤0.01%	342
2024 Q1	$3.07K	Hold	221	–	–	﹤0.01%	320
2023 Q4	$3.15K	Hold	221	–	–	﹤0.01%	308
2023 Q3	$3.42K	Hold	221	–	–	﹤0.01%	314
2023 Q2	$3.47K	Hold	221	–	–	﹤0.01%	303
2023 Q1	$3.64K	Hold	221	–	–	﹤0.01%	278
2022 Q4	$3.45K	Hold	221	–	–	﹤0.01%	250
2022 Q3	$3K	Hold	221	–	–	﹤0.01%	277
2022 Q2	$3K	Hold	221	–	–	﹤0.01%	263
2022 Q1	$3K	Hold	221	–	–	﹤0.01%	282
2021 Q4	$3K	Hold	221	–	–	﹤0.01%	290
2021 Q3	$4K	Hold	221	–	–	﹤0.01%	279
2021 Q2	$4K	Hold	221	–	–	﹤0.01%	277
2021 Q1	$4K	Hold	221	–	–	﹤0.01%	249
2020 Q4	$4K	Hold	221	–	–	﹤0.01%	233
2020 Q3	$3K	Hold	221	–	–	﹤0.01%	155
2020 Q2	$3K	Hold	221	–	–	﹤0.01%	218
2020 Q1	$3K	Hold	221	–	–	﹤0.01%	221
2019 Q4	$4K	Hold	221	–	–	﹤0.01%	249
2019 Q3	$3K	Hold	221	–	–	﹤0.01%	216
2019 Q2	$4K	Hold	221	–	–	﹤0.01%	220
2019 Q1	$4K	Buy	+221	New	+$4.45K	﹤0.01%	208

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Riggs Asset Management's TAK Position: Q4 2024 in Review

Riggs Asset Management sold out of Takeda Pharmaceutical (TAK) in Q4 2024, closing a stake of 221 shares — an estimated $3.14K sold.

Riggs Asset Management first reported a position in TAK in Q1 2019 and held it in 23 quarters. The position peaked at $4K in Q3 2021. 302 funds tracked by Wall St. Rank hold TAK as of Q4 2024.

Riggs Asset Management reported no remaining Takeda Pharmaceutical position as of Q4 2024 after selling out during the quarter.
Riggs Asset Management sold 221 Takeda Pharmaceutical shares in Q4 2024, an estimated $3.14K.
Riggs Asset Management first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 23 quarters.
Riggs Asset Management's Takeda Pharmaceutical position peaked at $4K in Q3 2021.
302 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2024.

Based on Riggs Asset Management's 13F filing for Q4 2024, filed 24 Jan 2025.